This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International Europe

Poster Submission Deadline is April 7

  • 00
  • 00
  • 00
  • 00
Mark Your Calendar for BPI Europe 2023!
9-12 May 2023RAI in Amsterdam

Ronan Kelly
Director Biology Protein Optimization at Eli Lilly


Ronan M. Kelly received his Ph.D. from the University of Groningen, the Netherlands, in 2009 where he worked on protein engineering and structural/enzymatic characterization of carbohydrate-modifying enzymes. Shortly after, Ronan joined N.I.B.R.T, Dublin, as an Eli Lilly funded postdoctoral scientist where he explored CHO cell glycoengineering strategies to enhance the effector function of IgG1 mAbs. Ronan then moved to the technical mAb manufacturing team at Eli Lilly before transitioning to the cell line development group in Indianapolis. Here he focused on enhancing CHO cell line productivity while also streamlining the overall clinical cell line generation process, which played a key role in the acceleration strategy for the Lilly SARS-CoV-2 mAbs. More recently, Ronan leads a discovery team focused on the expression and purification of recombinant proteins from both mammalian and bacterial systems.

Agenda Sessions

  • Power of Platform to Accelerate Therapeutics Beyond a Pandemic